Uganda Procures Antiretroviral Treatment For 350,000 HIV-Positive People, Health Minister Says
Main Category: HIV / AIDSArticle Date: 09 Feb 2009 - 2:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
5 (1 votes) |
Uganda's government has obtained antiretroviral drugs to provide 350,000 HIV-positive people with the therapy under its treatment program, Health Minister Stephen Mallinga announced recently, the New Vision/AllAfrica.com reports. According to Mallinga, 150,000 people currently have access to antiretrovirals, and the government aimed to add 200,000 people to this group. Mallinga said that Uganda's antiretroviral treatment program is one of the leading programs in Africa, with treatment initiatives available in 11 referral hospitals nationwide. The treatment program also will be introduced in health centers, according to Mallinga. He added that about 25% of people in Uganda are aware of their HIV status and that the program aims to promote HIV/AIDS awareness. Mallinga also noted that HIV/AIDS is contributing to the spread of tuberculosis in the country.
The New Vision/AllAfrica.com reports that the health ministry has expanded eligibility for enrollment in the antiretroviral program by raising the eligible CD4+ T cell count to 350 from 200. Nathan Kenya, the clinical and community services health director, said the previous enrollment criteria were "getting inadequate" (Buryegyeya, New Vision/AllAfrica.com, 2/4).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/138265.php>
APA
http://www.medicalnewstoday.com/releases/138265.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




